Hypopigmentation Disorder Treatment Market Trends, Size 2031

Hypopigmentation Disorder Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (Topical Drugs, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, and Others), Disease Indication (Pityriasis Alba, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation, and Others), End User (Aesthetic Clinics, Dermatology Centers, and Hospitals), and Geography

  • Report Code : TIPRE00004312
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

Hypopigmentation disorder treatment market value is expected to grow from US$ 4.4 billion in 2023 to US$ 6.7 billion by 2031; the market is estimated to record a CAGR of 5.41% from 2023 to 2031.

Market Insights and Analyst View:

Hypopigmentation disorders may further develop into depigmentation disorders. It is a condition wherein skin pigment levels are below optimum, unlike depigmentation conditions that occur due to the complete removal of pigments. Major factors driving the hypopigmentation disorder treatment market growth are the rising awareness related to hypopigmentation disorders, technological advancements in aesthetic treatments, and a continuous surge in the aging population. Moreover, increasing incidences of disorders related to hypopigmentation, such as albinism, post-hypopigmentation, and vitiligo, are anticipated to fuel the hypopigmentation disorders treatment market in the coming years. Further, growing consumer spending on skin health and awareness related to treatment is predicted to benefit this market in the near future. The introduction of natural and plant-based components is expected to bring hypopigmentation disorder treatment market trends in the coming years, as these products have been critical in meeting the global demand for cosmeceutical products so far. The cost of cosmetic treatments and surgery, on the other hand, restricts the market growth.

According to the National Clinical Trials (NCT) registry, in June 2020, Incyte Corporation conducted a phase II clinical trial for Ruxolitinib to evaluate its safety and efficacy in treating vitiligo in subjects enrolled in the US. Thus, the increasing number of clinical trials associated with hypopigmentation disorders is another key factor bolstering the market.

Growth Drivers and Challenges:

Increasing Prevalence of Hypopigmentary Disorders Propels Market Growth

Pityriasis alba, vitiligo, albinism, and post-inflammatory hypopigmentation are among the major disease indications associated with hypopigmentation disorders. Vitiligo is a commonly occurring disease indication across the world. According to a study published in the Dermatology Practical and Conceptual in December 2023, Vitiligo is a prevalent skin condition affecting both genders. Nonetheless, it is more prevalent in females, and more than 60% of patients experience disease onset before the age of 30. Rising incidences and prevalence of vitiligo are anticipated to further contribute to the growing demand for hypopigmentation treatments.

According to an article published in Zagazig University Medical Journal in March 2023, hypopigmentation disorders are a common group of dermatoses in pediatrics; the prevalence of hypopigmentation disorders varies from country to country, ranging from 3.6% to 9.9%. Furthermore, the advent and adoption of minimally invasive procedures, shorter hospital admittance time, and lesser pain and fewer complications associated with procedures have been pivotal for the growing popularity of minimally invasive procedures. According to the American Society of Plastic Surgeons (ASPS) in 2021, the number of minimally invasive cosmetic procedures performed in the US has surged by nearly 200% since 2000. Thus, the growing preference for minimally invasive cosmetic procedures further propels the hypopigmentation disorder treatment market growth. On the other hand, the cost of light therapy for disease indications such as vitiligo and albinism is high. Moreover, surgical procedures to treat vitiligo procedures are highly expensive. Thus, the high cost of treatments limits their adoption, thereby limiting the growth of the hypopigmentation disorder treatment market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Hypopigmentation Disorder Treatment Market: Strategic Insights

Market Size Value inUS$ 4.4 billion in 2023
Market Size Value byUS$ 6.7 billion by 2031
Growth rateCAGR of 5.41% from 2023 to 2031
Forecast Period2023-2031
Base Year2023
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The hypopigmentation disorder treatment market analysis has been carried out by considering the following segments: treatment, disease indication, and end user. The geographic scope of the hypopigmentation disorder treatment market report includes North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Segmental Analysis:

Treatment-Based Insights

Based on treatment, the market is segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, phototherapy, and others. The topical drugs segment held the largest hypopigmentation disorder treatment market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Disease Indication-Based Insights

Based on disease indication, the hypopigmentation disorder treatment market is segmented into pityriasis alba, albinism, vitiligo, post-inflammatory hypopigmentation, and others. The vitiligo segment held a significant market share by 2023, and it is expected to register the highest CAGR during 2023–2031.

End User-Based Insights

In terms of end user, the market is categorized into aesthetics clinics, dermatology centers, and hospitals. The aesthetics clinics segment held the largest hypopigmentation disorder treatment market share in 2023; it is further anticipated to register the highest CAGR in the market during 2023–2031.

End User-Based Insights
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Regional Analysis:

North America held the largest share of the hypopigmentation disorder treatment market in 2023, and it is projected to maintain its dominance (in terms of share) during the forecast period. The US dominates the market in this region (with the largest share) and the world. Well-established healthcare infrastructure, rising consciousness among people about their skin health, increasing prevalence of diseases associated with hypopigmentation disorders, and significant presence of companies that provide attractive treatment options for patients with post-inflammatory hyperpigmentation are among the noteworthy factors driving the market growth in North America. Further, beauty concerns with the rising beauty standards among Asians, a large number of companies entering the market, and the continued growth of established players are among the key factors contributing to the expansion of the hypopigmentation disorder treatment market size in Asia Pacific.

Competitive Landscape and Key Companies:

The hypopigmentation disorder treatment market forecast can help stakeholders in this marketplace plan their growth strategies. Allergan, SkinCeuticals, Pierre Fabre Group, Incyte Corporation, Episciences Inc., Phio Pharmaceuticals, Obagi Cosmeceuticals LLC, Alvogen, Bella Aurora, AbbVie are a few key companies profiled in the hypopigmentation disorder treatment market report. These companies focus on expanding their product offerings to meet the growing consumer demand across the world. Their global presence allows them to serve many customers.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Treatment, Disease Indication, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

What factors drive the hypopigmentation disorder treatment market?

Growing prevalence of skin diseases and rising demand for affordable and effective treatment solution globally. In 2023, the World Health Organization released estimates that skin diseases impacted over 1.8 million people worldwide. However, the stringent regulatory processes and high cost of hypopigmentation disorder treatment is expected to hinder the growth of the hypopigmentation disorder treatment market.

What is Hypopigmentation Disorders?

Hypopigmentation disorders are skin conditions caused due to loss in skin color. These disorders include vitiligo, albinism, and pityriasis alba among other disorders. Treatment depends on the severity of specific disease conditions.

What was the estimated hypopigmentation disorder treatment market size in 2023?

The hypopigmentation disorder treatment market was valued at US$ 4,428.57 million in 2023.

Who are the major players in the hypopigmentation disorder treatment market?

The hypopigmentation disorder treatment market has major market players, including Allergan, SkinCeuticals, Pierre Fabre, EpiSciences, Incyte, STRATA Skin Sciences, AVITA Medical, Galderma S.A.

Which treatment type segment dominates the hypopigmentation disorder treatment market?

Based on type, the topical drugs segment in the hypopigmentation disorder treatment market is expected to record the fastest CAGR from 2023 to 2031. Factor such as ease of convenience of taking these drugs, increasing number of topical drugs to treat hypopigmentary scars.

What are the growth estimates for the hypopigmentation disorder treatment market till 2031?

The hypopigmentation disorder treatment market is expected to be valued at US$ 6,750.10 million in 2030.

Which hypopigmentation disease indication segment dominates the hypopigmentation disorder treatment market?

Based on disease indication type, the hypopigmentation disorder treatment market is segmented into pityriasis alba, vitiligo, albinism, PIH and others. Vitiligo is anticipated to gain significant traction in the upcoming years. Rising prevalence of vitiligo globally and number of patients suffering from this disease is expected to drive the market growth.

The List of Companies - Hypopigmentation Disorder Treatment Market

  1. Allergan
  2. SkinCeuticals
  3. Pierre Fabre
  4. Obagi Cosmeceuticals LLC
  5. Incyte
  6. Galderma S.A.
  7. TeVido BioDevices, Inc.
  8. STRATA Skin Sciences
  9. AVITA Medical
  10. Courage + Khazaka electronic GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Hypopigmentation Disorder Treatment Market